Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05567133 · ClinicalTrials.gov registry record
Risk Indicators of Sarcoidosis Evolution-Unified Protocol
A clinical trial of Sarcoidosis, Pulmonary, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT05567133: Recruiting study of Sarcoidosis, Pulmonary, sponsored by University of California, San Francisco.
NCT05567133 is a study of Sarcoidosis, Pulmonary that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants, above the 39-participant average among 3 other Sarcoidosis, Pulmonary trials with a reported enrollment target (413% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05567133, a study of Sarcoidosis, Pulmonary, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.
Primary Outcome
Forced vital capacity (FVC) is the total amount of air in liters exhaled during a forced maneuver.
Conditions Studied
Study Locations (2)
Maryland
- University of Maryland - Baltimore
Texas
- UT Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2030-03-30 |
What NCT05567133 shows while recruiting
NCT05567133 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 39-participant average among 3 other Sarcoidosis, Pulmonary trials with a reported enrollment target (413% higher).
The record links to 1 condition, with Sarcoidosis, Pulmonary appearing as the primary indexed condition, and to 0 interventions.
NCT05567133 reports a single indexed study location in Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT05567133 about?
NCT05567133 is a clinical study titled "Risk Indicators of Sarcoidosis Evolution-Unified Protocol". The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.
What is the current status of trial NCT05567133?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-01-10. Estimated completion is 2030-03-30.
What conditions does trial NCT05567133 study?
This clinical trial studies the following conditions: Sarcoidosis, Pulmonary.
Who is sponsoring clinical trial NCT05567133?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05567133 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoidosis, Pulmonary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI